Functional magnetic resonance imaging (fMRI) and effects of L-dopa on visual function in normal and amblyopic subjects

Transactions of the American Ophthalmological Society

Volumn 101, Issue , 2003, Pages 401-415

  Rogers, Gary L ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBIDOPA PLUS LEVODOPA; LEVODOPA;

AMBLYOPIA; BINOCULAR VISION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTRAST SENSITIVITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VISION; VISUAL ACUITY; VISUAL CORTEX;

ADULT; AMBLYOPIA; CASE-CONTROL STUDIES; CONTRAST SENSITIVITY; DEPTH PERCEPTION; DOPAMINE AGENTS; FEMALE; HUMANS; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHOPHYSICS; VISION; VISION, BINOCULAR; VISUAL ACUITY;

EID: 1142274398     PISSN: 00659533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. National Society to Prevent Blindness. Vision Problems in the U.S. Data Analysis. Definitions, Data Sources, Detailed Data Tables, Analysis, Interpretations. New York: National Society to Prevent Blindness; 1980, Publication P-10.
2. Oliver M, Nawratzki I. Screening of pre-school children for ocular anomalies. II. Amblyopia. Prevalence and therapeutic results at different ages. Br J Ophthalmol 1971;55:467-471.
3. Sorsby A, Sheridan M, Leary GA. Vision, visual acuity, and ocular refraction in young men. BMJ 1960;1394-1398.
4. Hillis A, Flynn JT, Hawkins BS. The evolving concept of amblyopia: a challenge to epidemiologists. Am J Epidemiol 1983;118:192-205.
5. Flom MC, Neumaier RW. Prevalence of amblyopia. Public Health Rep 1966;8:329-341.
6. Mazow ML, Chuang A, Vital MC, et al. 1999 Costenbader Lecture. Outcome study in amblyopia: treatment and practice pattern variations. J AAPOS 2000;4:109.
7. Simons K, Gotzler KC, Vitale S. Penalization versus part-time occlusion and binocular outcome in treatment of strabismic amblyopia. Ophthalmology 1997;104:2156-2160.
8. Scott WE, Dickey CF. Stability of visual acuity in amblyopic patients after visualmaturity. Graefes Arch Clin Exp Ophthalmol 1988;226:154-157.
9. Harrad R. The efficacy of occlusion for strabismic amblyopia. Can an optimal duration be identified? Br J Ophthalmol 2000;84:561.
10. Buffon C. Differences in the visual performance of the two eyes. In: Noorden GN, ed. The History of Strabismology. Chap 1. Strabismology from its beginnings to the middle of the 19th century. IV. Theories of the etiology and pathogenesis of strabismus. Remky H, ed. Belgium: J.P. Wayenborgh; 2002:15.
11. The Pediatric Eye Disease Investigator Group. A randomized trial of atropine vs patching for treatment of moderate amblyopia in children. Arch Ophthalmol 2002;120:268-278.
12. Gottlob I, Stangler-Zuschrott E. Effect of levodopa on contrast sensitivity and scotomas in human amblyopia. Invest Ophthalmol Vis Sci 1990;31:776-780.
13. Gottlob I, Charlier J, Reinecke RD. Visual acuities and scotomas after one-week levodopa administration in human amblyopia. Invest Ophthalmol Vis Sci 1992;33:2722-2728.
14. Leguire LE, Rogers GL, Walson PD, et al. Occlusion and levodopa-carbidopa treatment for childhood amblyopia. J AAPOS 1998;2:257-264.
15. Leguire LE, Rogers GL, Bremer DL, et al. Levodopa and childhood amblyopia. J Pediatr Ophthalmol Strabismus 1992;29:290-298.
16. Leguire LE, Rogers GL, Bremer DL, et al. Levodopa/carbidopa for childhood amblyopia. Invest Ophthalmol Vis Sci 1993;34:3090-3095.
17. Leguire LE, Walson PD, Rogers GL, et al. Longitudinal study of levodopa/carbidopa for childhood amblyopia. J Pediatr Ophthalmol Strabismus 1993;30:354-360.
18. Leguire LE, Walson PD, Rogers GL, et al. Levodopa/carbidopa treatment for amblyopia in older children. J Pediatr Ophthalmol Strabismus 1995;32:143-151.
19. Demer JL, von Noorden GK, Volkow ND, et al. Imaging of cerebral blood flow and metabolism in amblyopia by positron emission tomography. Am J Ophthalmol 1988;105:337-347.
20. Demer JL, von Noorden GK, Volkow ND, et al. Brain activity in amblyopia. Am Orthopt J 1991;41:56-66.
21. Demer JL. Positron emission tomographic studies of cortical function in human amblyopia. Neurosci Biobehav Rev 1993;17:469-476.
22. Ochi H. Brain, heart and tumor imaging: updated PET and MRI. In: Proceedings of the 2nd International Osaka City University Symposium on Brain, Heart and Tumor Imaging. Osaka, Japan, Oct 2-4, 1994.
23. Algaze A, Roberts CJ, Leguire LE, et al. Functional magnetic resonance imaging as a tool for investigating amblyopia in the human visual cortex. J AAPOS 2002;6:300-308.
24. Fox PT, Raichle ME. Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc Natl Acad Sci USA 1986;83:1140-1144.
25. Bandettini PA, Jesmanowicz A, Wong E, et al. Processing strategies for time-course data sets in functional MRI of the human brain. Magn Reson Med 1993;30:161-173.
26. Cox RW, Hyde JS. Software tools for analysis and visualization of fMRI data. NMR Biomed 1997;10:171-178.
27. Wiesel TN, Hubel DH. Single cell responses in striate cortex if kittens deprived of vision in one eye. J Neurophysiol 1963;26:1003-1017.
28. Hubel DH, Wiesel TN. Functional architecture of macaque monkey visual cortex. Proc R Soc Lond B Biol Sci 1977;28;198:1-59.
29. Hubel DH, Wiesel TN, LeVay S. Plasticity of ocular dominance columns in monkey striate cortex. Philos Trans R Soc Lond B Biol Sci 1977;278:377-409.
30. LeVay S, Wiesel TN, Hubel DH. The development of ocular dominance columns in normal and visually deprived monkeys. J Comp Neurol 1980;19:1-51.
31. TN. Postnatal development of the visual cortex and the influence of environment. Nature 1982;299:583-591.
32. Kasamatsu T, Pettigrew JD, Ary M. Restoration of visual cortical plasticity by local microperfusion of norepinephrine. J Comp Neurol 1979;185:163-181.
33. Kasamatsu T, Pettigrew JD. Preservation of binocularity after monocular deprivation in the striate cortex of kittens treated with 6-hydroxydopamine. J Comp Neurol 1979;185:139-161.
34. Imamura K, Kasamatsu T. Interaction of noradrenergic and cholinergic systems in regulation of ocular dominance plasticity. Neurosci Res 1989;6:519-536.
35. Leguire LE, Komaromy KL, Nairus TM, et al. Long-term follow-up of L-dopa treatment in children with amblyopia. J Pediatr Ophthalmol Strabismus 2002;39:326-330.
36. Leguire LE, Nairus T, Walson P. Influence of levodopa/carbidopa on body temperature in children. Curr Ther Res 1995;56:333-340.
37. Leguire LE, Rogers GL, Bremer DL, et al. A comparison of contrast sensitivity between strabismic and anisometropic amblyopia in children. Binocul Vis Strabismus Q 1989;4:179-186.
38. Leguire LE, Rogers GL, Bremer DL. Functional amblyopia is a single continuum of visual impairment on contrast sensitivity functions. Binocul Vis Strabismus Q 1987;2:199-208.
39. Wali N, Leguire LE, Rogers GL, et al. CSF interocular interactions in childhood amblyopia. Optom Vis Sci 1991;68:81-87.
40. Hess RG, Howell ER. The threshold contrast sensitivity function in strabismic amblyopia. Vis Res 1977;17:1049-1056.
41. Rogers GL, Bremer DL, Leguire LE. The contrast sensitivity function and childhood amblyopia. Am J Ophthalmol 1987;104:64-68.
42. Martin E, Joeri P, Loenneker T, et al. Visual processing in infants and children studied using functional MRI. Pediatr Res 1999;46:135-140.
43. Altman NR, Bernel B. Brain activation in sedated children: auditory and visual functional MRI imaging. Radiology 2001;221:56-63.
44. Qu Y, Eysel UT, Vandesande F, et al. Effect of partial sensory deprivation on monoaminergic neuromodulators in striate cortex of adult cat. Neuroscience 2000;101:863-868.
45. Goodyear BG, Nicolle DA, Humphrey GK, et al. BOLD fMRI response of early visual areas to perceived contrast in human amblyopia. J Neurophysiol 2000;84:1907-1913.
46. Ginsburg AP. Spatial filtering and visual form perception. In: Boff KR, Kaufman L, Thomas JP, eds. Handbook of Perception and Human Performance. New York: Wiley, 1986;2(34):1-41
47. Campbell FW, Robson JG. Application of Fourier analysis to the visibility of gratings. J Physiol 1968;197:551-566.
48. Tolhurst DJ. Separate channels for the analysis of the shape and the movement of moving visual stimulus. J Physiol 1973;231:385-402.
49. Martin E, Joeri P, Loenneker T, et al. Visual processing in infants and children studied using functional MRI. Pediatr Res 1999;46:135-140.
50. Zhao Y, Kerscher N, Eysel U, et al. Changes of contrast gain in cat dorsal lateral geniculate nucleus by dopamine receptor agonists. Neuroreport 2001;17;12(13):2939-2945.
51. Medoff DR, Tagamets MA. Neural networks: neural systems III. Am J Psychiatry 2000;157:1571.
52. Tagamets MA, Horwitz B. Interpreting PET and fMRI measures of functional neural activity: the effects of synaptic inhibition on cortical activation in human imaging studies. Brain Res Bull 2001;54:267-273.